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Abstract.  To study the effects of myc oncogene on 
muscle differentiation,  we infected the murine skeletal 
muscle cell line C2C12 with retroviral vectors encod- 
ing various forms of avian c- or v-myc oncogene. 
myc expression induced cell transformation  but, un- 
like many other oncogenes, prevented neither bio- 
chemical differentiation,  nor commitment (irreversible 
withdrawal from the cell cycle). Yet, myotube forma- 
tion by fusion of differentiated cells was strongly in- 
hibited.  Comparison of uninfected C2C12 myotubes 
with differentiated myc-expressing C2C12 did not re- 
veal consistent differences in the expression of several 
muscle regulatory or structural genes. The present 
results lead us to conclude that transformation by myc 
is compatible with differentiation in C2C12 cells. 
myc expression induced cell death under growth re- 
stricting conditions.  Differentiated cells escaped cell 
death despite continuing expression of myc,  suggesting 
that the muscle differentiation programme interferes 
with the mechanism of myc-induced cell death. 
Cocultivation of v-myc-transformed  C2C12 cells with 
normal fibroblasts or myoblasts restored fusion compe- 
tence and revealed two distinguishable mechanisms 
that lead to correction of the fusion defect. 
S 
KELETAL muscle cell differentiation  involves irreversi- 
ble withdrawal from cell cycle (also referred to as com- 
mitment)  and  coordinate  activation  of a  number  of 
unlinked,  muscle-specific genes  (biochemical  differentia- 
tion) (Pearson and Epstein, 1982). Terminally differentiated 
myocytes have  the option to  fuse with one another,  thus 
generating  multinucleated myotubes. The mutual exclusion 
between cellular proliferation  and expression  of differentia- 
tion markers is maintained  by myogenic cells in vitro and is 
particularly evident in myogenic  cell lines  that proliferate 
indefinitely in mitogen-rich culture medium and are induced 
to  differentiate  in  mitogen-poor  medium  (Clegg  et  al., 
1987).  The ordered sequence of events that leads to myo- 
genic terminal  differentiation  appears to be controlled by a 
small  number of regulatory genes that include the MyoD 
family  of muscle-specific transcription  factors  and  their 
positive and negative coregulators E2A and Id (Olson, 1990; 
Weintraub  et al.,  1991). 
During the last decade, a growing  number of genes  in- 
volved in  cell transformation  and  tumorigenesis,  the  on- 
cogenes,  have  been  identified.  When  expressed in  fibro- 
blasts, a large subset of these genes promote proliferation, 
thus contributing  to transformation  (Weinberg,  1989).  By 
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promoting proliferation  and partially upsetting  its  regula- 
tion, the oncogenes allow cells to proliferate in conditions 
normally not supporting cell growth (e.g., confluence, or ab- 
sence of exogenous growth factors),  myc constitutes  an in- 
teresting  exception  to this  paradigm.  The proto-oncogene 
c-myc  is  ubiquitously  expressed  and  required  for  cell 
proliferation  (Liischer  and Eisenman,  1990). Its oncogenic 
form can transform  cells alone (Vennstr6m et al.,  1984) or 
in conjunction  with other oncogenes (Land et al.,  1983). 
However, when mammalian  fibroblasts are forced to express 
myc in culture conditions  not sustaining  growth,  they un- 
dergo apoptosis (Evan et al.,  1992). 
Constitutive  expression  of viral  oncogenes  or  cellular 
proto-oncogenes  has  been  shown  to  prevent  myogenic 
differentiation  in early passage avian myoblasts (Alem~ and 
Tatb, 1987) as well as mammalian  cell lines (Schneider  and 
Olson,  1988).  In particular,  transformation  of the mouse 
C2C12 cell line by activated  ms (Konieczny et al.,  1989), 
(Lassar et al., 1989), v-fos (Lassar et al., 1989), c-jun (Ben- 
gal et al.,  1992), or v-src (Gauzzi,  C., and S. Alem~, per- 
sonal  communication;  Zanetti,  A.,  unpublished  work) 
results  in the extinction  of MyoD transcription,  and this 
represents  one  mechanism  to  explain  the  inhibition  of 
differentiation.  On the other hand,  transformation  of un- 
established quail myoblasts by v-src (Falcone et al., 1991) or 
v-jun (Grossi et al.,  1991) prevents terminal  differentiation 
without requiring transcriptional  silencing of MyoD, as also 
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large-T antigen (Maione et al.,  1992).  In the case of v-src- 
transformed quail  myoblasts,  it has  been  shown that the 
transactivating function of MyoD appears to be impaired, 
thereby providing a second mechanism through which trans- 
formation can inhibit myogenic differentiation (Falcone et 
al.,  1991). 
While there is a general consensus that the expression of 
most known oncogenes prevents myogenesis, the effects of 
the myc oncogene in muscle cells appear to be quite variable, 
ranging  from  partial  inhibition  by  exogenous  c-myc  in 
BC3H1 cells (Schneider et al.,  1987),  a non-fusing mouse 
myogenic cell line (Schubert et al., 1974), to very strong in- 
hibition by v-myc in quail myoblasts (Falcone et al.,  1985). 
Given the differences between experiments with continuous 
cell lines and those with unestablished myoblasts and the 
widespread use of the C2C12 myogenic cell line as a model 
for myogenesis, we have decided to analyze the effects of 
c-and v-myc oncogene expression in C2C12 cells. 
The results presented here indicate that v-myc and c-myc 
disrupt growth control in C2C12 cells. Contrary to the more 
common findings, myc-transformed C2C12 cells retain the 
ability to undergo commitment and biochemical differentia- 
tion. However, they are strikingly unable to fuse into mul- 
tinucleated myotubes, in spite of conspicuous induction and 
accumulation of  muscle-specific structural proteins. The un- 
usual fusion-defective  phenotype ofmyc-transformed C2C12 
cells  is  readily  suppressed  by  cocultivation  with  either 
fusion-competent heterologous myoblasts or normal fibro- 
blasts via two distinguishable mechanisms. One mechanism 
appears  to involve the phenotypic reversion of myc-trans- 
formed cells and leads to the formation of multinucleated 
myotubes whose nuclei derive exclusively from myc-trans- 
formed cells. The other mechanism is represented by the re- 
cruitment of differentiated, mononucleated myc-expressing 
cells into myotubes formed by fusion competent myoblasts, 
that leads to the formation of"hybrid" myotubes, containing 
nuclei derived from both normal and transformed cells. The 
present data suggest that fusion of differentiated myocytes, 
although usually sequentially linked to commitment and bio- 
chemical differentiation, can be specifically uncoupled from 
the  rest  of the  myogenic program  by  the  action  of myc 
oncogene. 
Materials and Methods 
Cells and Tissue Culture Media 
C2C12 cells and Rat-2 fibroblasts were kindly provided by S. Alem~ (Inst. 
of Cell Biology,  C.  N.  R.,  Rome,  Italy) and P.  Amati (Universit~  "La 
Spienza  ~, Rome, Italy). L6 and L8 cells are a generous gift of S. Adamo 
(Universit~ "La Spienza", Rome, Italy) and D. Yaffe (Weizmann Institute, 
Rahovot, Israel).  Growth medium was Dulbecco's modified Eagle's medium 
supplemented with  10%  fetal bovine serum.  Serum-free (SF)  1 medium 
was Dulbecco's modified Eagle's medium supplemented with 10 tzg/ml insu- 
lin, and 5/~g/ml transferdn, myc-expressing cells were routinely cultured 
in collagen-coated dishes, due to their poor adherence on plastic. All experi- 
ments were performed in coated dishes. 
Sofi-agar assays for anchorage-independent growth were carried out as 
described (Bignami et al.,  1988b). 
1. Abbr~:iations used in this paper: AraC, cytosine/3-o-arabinofuranoside; 
BrdU,  5-bromo-2'-deoxyuridine; IE immunofluorescence;  MHC, myosin 
heavy chain; SE serum-free. 
Viruses and Infections 
MMCV is a replication-defective  recombinant retrovirus carrying the avian 
v-myc  °m° oncogene  (Vennstr6m et al.,  1984). The MLV helper virus is a 
kind gift of 1". Graf (EMBL, Heidelberg,  Germany). 
A schematic representation of the pBabe viruses is depicted in Fig.  1. 
pBabe-c-myc was generated by cloning an artificial cDNA containing an ex- 
onII/exonIII avian c-myc (Crouch et al., 1990) into the replication defective 
retrovirus pBabeneo (Morgenstern and Land, 1990), using BamHI linkers. 
A c/v-myc chimaera was constructed by fusing the 5' end of avian c-myc to 
the 3' end of MC29 v-myc at the Sstl site.  The resulting chimaera, which 
contains the point mutations associated  with MC29 v-myc (Walter et al., 
1986) but lacks any gag sequences, was subsequently cloned into pBabeneo 
using BamHI linkers,  generating pBabe-c/v-myc. 
~b-2 cells expressing  the pEabe viruses were generated by transfection 
using standard calcium phosphate precipitation (Crouch et al.,  1990),  al- 
lowing  the production of helper-free pBabe virus stocks  (Mann et al., 
1983). Growth conditions were as described for C2C12 ceils (see above), 
with neo selection performed using 1 mg/ml G418. 
Infections were  performed in 60 nun dishes.  Cells  (2  x  105) were 
seeded and treated for 1-3 h with 2.5/~g/ml polybrene in growth medium. 
1 ml of viral stock was added and infection was allowed to proceed over- 
night. On the next day, ceils were  fed growth  medium. For replication- 
defective viruses, G418 selection began on the second day after infection. 
Immunofluorescence and DNA Staining 
The following antisera and mAbs were used for immunoeytochemistry and 
immunofluorescence  (IF): MyoD, rabbit polyclonal antiserum kindly pro- 
vided by H. Weintraub (Fred Hutchinson Center,  Seattle, WA); myogenin, 
mAb F5D (Wright et al.,  1991), made available by G. Cossu (Universit~ 
"La Spienza; Rome); 5-bromo-2'-deoxyuridine  (BrdU): mAb-DNAse mix- 
ture (Amersham, Amersham, UK); myosin heavy chain (MHC): mAb MF- 
20 (Bader et al., 1982) (a kind gift olD. Fischrnan; Cornell University, New 
York); Troponin T, mAb (Amersham); Myc,  rabbit polyclonal  antiserum 
raised against avian v-Myc  (generously  provided by K.  Moelling, Max- 
Planck Institut, Berlin, Germany). mAbs were detected by affinity-purified 
goat anti-mouse IgG (Organon Teknika, West Chester, PA). Rabbit antisera 
were detected by affinity-purified goat anti-rabbit IgG (Organon Teknika). 
Secondary  antisera were conjugated  with either rhodamine or fluorescein. 
In experiments involving simultaneous detection of BrdU and MHC by two 
mAbs, the anti-BrdU mAb was detected first by a peroxidase-conjugated 
anti-mouse Ig antiserum supplied in the Cell Proliferation kit (Amersham), 
that was reacted with diaminobenzidine; anti-MHC IF was then carded out 
as described above. Nuclei were stained after IF treatments by incubating 
the permeabilized cells for 3 min with a 0.1/zg/ml solution of Hoechst 33258 
dye in phosphate-buffered  saline. 
Cocultivations 
Mixed cultures of proliferating v-myc-transformed  C2C12 cells (C2C12- 
[v-myc]) and normal cells were set up by seeding simultaneously the cells 
into collagen-coated,  35 mm dishes as follows:  103 C2C12(v-myc) +  2  × 
105 Rat-2 or 3  x  104 C2C12(v-myc) +  10  s quail myoblasts. The next day, 
the cultures were shifted to serum-free medium. 3 d later, the differentiated 
cultures were fixed  in 50%  methanol/acetone (vol/vol)  and stained for 
fluorescent detection of MHC and DNA. Rat and quail nuclei were stained 
homogeneously  by the Hoechst 33258  dye,  while mouse nuclei showed 
LTR  LTR 
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pBabe-c/v-myc 
Figure 1.  Structure of the Babe viruses, pBabe-c-myc and pBabe- 
c/v-myc are replication defective retroviruses which encode an exon 
H/exon HI avian c-myc and a c-myc/v-myc chimaera, respectively. 
The  c-myc  sequence  is  represented  by  the  open box,  while the 
MC29 v-myc  sequence is indicated by the hatched area. 
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(v-myc) cells were induced to differentiate in SF medium for 3-4 d, adding 
50  ttM  cytosine ~-D-arabinofuranoside  (AraC)  on  day  2  to  eliminate 
undifferentiated, proliferating cells.  After washing out AraC, quail myo- 
blasts (2  x  10  5) or Rat-2 fibroblasts (4  x  10  5) were added in growth me- 
dium and after a few hours mixed cultures were shifted to SF medium and 
incubated for further 3  d. Cultures were then analyzed as above. 
Results 
Transformation by myc Prevents Fusion But Not 
Differentiation of  C2C12 Myoblasts 
To study the effects of the constitutive expression of myc on 
muscle differentiation, we infected the mouse myoblast cell 
line  C2C12  with  the  v-myc-expressing  retroviral  vector 
MMCV, along with the MLV helper virus. Since the pres- 
ence of the helper virus allowed replication of MMCV, the 
vast majority of the ceils became rapidly infected. Accord- 
ingly, the cells became smaller, more round in shape, loosely 
attached, and showed prominent nucleoli. Their doubling 
time  was  evidently  shorter  and  their  saturation  density 
higher, compared to those of MLV- and mock-infected cells. 
v-myc expression was verified by Northern blot and ascer- 
tained to be present in the great majority of the cells by IF 
studies (see below). 
Because  the  MMCV-infected  cells  (C2C12[MMCV]) 
showed morphological conversion, we determined whether 
they were capable of anchorage-independent proliferation. 
Cells were seeded in soft agar and colony formation was as- 
sessed.  Table I shows that C2C12(MMCV) readily formed 
colonies in suspension, while parental cells failed to grow. 
Based on these data and on the other growth properties of 
these cells, we regard C2C12(MMCV) as transformed. 
Since transformation virtually always antagonizes muscle 
differentiation, we assessed the ability of C2C12(MMCV) to 
differentiate. Muscle differentiation was induced by feeding 
the cells serum-free medium, depriving them of growth fac- 
tors. Biochemical differentiation  was determined by IF stain- 
ing of MHC,  a  muscle-specific marker.  C2C12(MMCV) 
cells underwent biochemical differentiation  with an apparent 
efficiency  similar to that of MLV-infected C2C12 ceils. How- 
ever, fusion was severely inhibited (Fig. 2 and Table II). Very 
few of the MHC-positive cells had more than one nucleus, 
even when grown at high density to promote fusion. Table 
II shows a representative experiment in which the differentia- 
tion index and the fusion index of C2C12(MMCV) and con- 
trol cells were compared. In spite of similar differentiation 
rates, fusion was virtually absent in C2C12(MMCV).  The 
Table L Anchorage-independent Growth of 
myc-infected C2C12 
Colonies 
Cells  (Percent +  SD) 
C2C12(MMCV)  40.5  5:4.5 
C2C12(-)  <0.1 
NDt 3T3(v-src)  34.6  + 1.7 
Cells were seeded in dupficate  60 mm dishes as specified  in Materials and 
Methods, at 1,000 cells/dish. Colonies were counted 23 d later. C2C12(-), 
mock-infected cells; NIH 3T3(v-src), NIH 3T3 cells transformed by v-src, ad- 
ded as positive controls. Results arc presented as percentage of colonies/number 
of cells seeded +SD. 
Figure  2. Phenotype of C2C12(MMCV) and parental C2C12 cells. 
Cells were induced to differentiate  in serum-free medium. 3 d later 
they were subjected to IF staining for MHC. (a) C2C12(MMCV); 
(b) C2C12. Bar, 100/zm. 
fusion index of C2C12(MMCV) never exceeded one percent 
in several  independent experiments. 
Despite the absence of fusion, a  striking result was the 
ability of transformed cells to differentiate at all. One possi- 
bility was that, within C2C12 cells, a subset of cells was not 
transformed, e.g., due to low v-myc expression levels.  To 
disprove this, we randomly isolated 14 independent C2C12- 
(MMCV) clones from soft agar. They all behaved very simi- 
laxly to the uncloned transformed cell line and showed dif- 
ferentiation indices up to and higher than 50%  (data not 
shown).  Thus,  anchorage-independent,  clonal  cell  lines 
were capable of differentiating efficiently in the appropriate 
conditions. Furthermore, double IF staining showed high ex- 
Table II. Fusion Index of C2C12  (MMCIO 
Cells  Differentiation  index  Fusion index 
C2C12(MMCV)  28  <1 
C2C12(MLV)  30  27 
C2C12(-)  40  37 
Ceils were seeded at 105 cells/35 nan dish, serum was removed on the next day, 
and 4 d later cells were fixed.  MHC was stained by indirect IF; nuclei were 
stained with Hoechst 33258 dye. Differentiation index, percentage of nuclei be- 
longing to MHC-positive cells; fusion index, percentage of nuclei belonging 
to ceils with three or more nuclei. At least 100 nuclei were counted for each 
data point. 
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ferentiated  cells.  C2C12- 
(MMCV)  and  C2C12 cells 
were induced to differentiate 
for 3 d,  and then stained by 
double IF to detect troponin 
T  and v-Myc protein and by 
Hoechst  33258 to  highlight 
the nuclei. Three views of the 
same microscopic field show- 
ing C2C12 cells (a-c). Three 
views of  the same microscopic 
field showing  C2C120VIMCV) 
(d-f). Photographs  show  MHC 
staining  (a  and  d),  v-Myc 
staining (b and e), and DNA 
staining (c and  f). Bar, 50 t~m. 
pression of v-myc in MHC-positive, differentiated cells (Fig. 
3). In conclusion, in C2C12 cells transformation by v-myc 
is compatible with differentiation. 
The BC3H1 cell line derives from a mouse brain tumor but 
behaves  in  many  respects  as  a  skeletal  muscle  cell  line 
(Schubert et al., 1974). It has been reported that these cells 
can undergo biochemical differentiation, but are unable to 
fuse.  More  importantly,  differentiated cells  lose  muscle- 
specific expression and reenter the cell cycle when stimu- 
lated by growth factors (Lathrop et al.,  1985).  We asked 
whether C2C12(MMCV)  would behave similarly.  C2C12- 
(MMCV)  were induced to differentiate in serum-free me- 
dium for 3 d  and then were fed medium containing 10 or 
20% fetal bovine serum and 20/~M BrdU. Cells were fixed 
after 12, 24, and 48 h and stained for MHC and BrdU, the 
latter as  a  marker of DNA  synthesis.  No double-positive 
cells were found at any time. Moreover, differentiated cells 
did not give rise to colonies upon serum stimulation (not 
shown). Thus, despite their impaired ability to fuse, C2C12- 
(MMCV) fully undergo commitment. 
Other myc-expressing Vectors 
The  phenotype  displayed  by  C2C12(MMCV)  was  unex- 
pected and somewhat at variance with previous results ob- 
tained in other systems by us and others, in that differentia- 
tion was allowed to occur. Consequently, we made an effort 
to verify whether our results applied only to this particular 
system or were applicable to other myc vectors and mam- 
malian cells. Two other retroviral vectors were used to infect 
C2C12  cells.  Babe-c-myc  expresses  the  chicken  proto- 
oncogene; Babe-c/v-myc  encodes a chimaeric molecule lack- 
ing the gag but retaining most of the myc moiety of v-myc 
(see Materials and Methods). Both viruses are replication- 
defective and  encode  the  neo  selectable  marker.  G418- 
selected C2C12  infected with  either virus,  referred to  as 
C2C12(c-myc) or C2C12(v-myc), displayed a phenotype vir- 
tually indistinguishable from that of C2C12(MMCV), with 
Babe-c-myc allowing slightly more fusion than MMCV (data 
not shown).  In particular,  cells infected with either virus 
differentiated  efficiently, fused very poorly, and formed colo- 
nies in  soft agar,  although Babe-c-myc-infected cells gave 
rise to smaller colonies. 
We have attempted to extend our findings to other mam- 
malian cell lines such as L6 and L8, using the Babe-clv-myc 
vector, but we could not reach firm conclusions. The major 
drawbacks were the different time and cell density require- 
ments displayed by these other cell lines to undergo differen- 
tiation after mitogen removal. While C2C12 can differentiate 
within 2-3 d, even at relatively low density, both L6 and L8 
require at least twice as long a time after reaching conflu- 
ence. As a consequence, v-myc-transformed  L6 and L8 cells 
underwent massive cell death (see below) before attaining 
the conditions necessary for their differentiation. Differen- 
tiated,  mononucleated myocytes-but virtually no myotubes- 
were indeed observed among the cells surviving at the end 
of the experiments; however, the cell density was too low to 
rule out that the lack of fusion was merely the result of the 
inability of the cells to contact one another. 
Differentiation Protects  from myc-induced Cell Death 
Recently it has been reported that forced expression of myc 
in fibroblasts induces apoptosis when they are cultivated in 
conditions in which normal cells would not proliferate (Evan 
et al.,  1992).  A  similar phenomenon was evident in myc- 
transformed myogenic cells.  C2C12(MMCV)  proliferated 
rapidly until they became confluent, then a wave ofceU death 
ensued. The same phenomenon was accurately reproducible 
upon serum starvation. Many cells detached from the sub- 
strate within a few hours, and eventually up to 50% of the 
ceils  were  lost.  Interestingly,  however,  those  cells  that 
differentiated following serum starvation did not die despite 
continued incubation in serum-free medium for as long as 1 
wk. This was true even though the differentiated cells con- 
tinued to express high levels of myc (see Fig. 3 for protein 
and Fig.  5  for mRNA).  In differentiation-inducing condi- 
tions,  extensive  cell  death  was  observed  in  c-  and  c/v- 
myc-transformed C2C12. Since in these cells exogenous myc 
mRNA levels do not vary significantly upon differentiation 
(see below), we conclude that differentiation protects from 
myc-induced cell death without selecting for cells that ex- 
press low levels of myc. 
Muscle-specific Gene Expression in 
myc-transformed Myoblasts 
Given the absence of fusion in differentiated cells, we asked 
whether the expression of a subset of muscle-specific struc- 
tural  genes  was  suppressed  in  myc-expressing myocytes. 
C2C12 cells infected with each of  the three viruses were ana- 
lyzed by Northern blot and IF for expression of a number of 
muscle-specific proteins. Upon differentiation, MHC, myo- 
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from cells exponentially  growing  fie#) or induced  to differentiate  for 
3 to 4 d (right). 25 ttg from each sample were loaded, separated on 
a 1.2% agarose gel, transferred to reinforced nitrocellulose  paper, 
and hybridized  with the indicated  probes. All probes were hybridized 
to the same filter except MCK, which was used on a different  blot. 
sin light:Chain 1, and muscle creatine kinase mRNAs were 
expressed,  at  levels  comparable  with  those  of wild-type 
C2C12 (Fig. 4). MHC and Troponin T were also analyzed 
by IF and found to be expressed similarly in all cell lines (see 
Fig. 3 for Troponin T and Fig. 6 for MHC). The expression 
of two surface molecules possibly involved in fusion was 
analyzed. M-cadherin, a muscle-specific cadherin (Donalies 
et al., 1991), and N-CAM, a widely expressed cell-adhesion 
molecule (reviewed in Edelman and Crossin, 1991). Fig. 4 
shows  that  M-cadherin  mRNA  was  indeed  reduced  in 
proliferating cells, but was at wild-type level in differentiated 
cells. The pattern of N-CAM did not show significant varia- 
tions (Fig. 4). Thus, in differentiated  cells, none of  the struc- 
tural genes we examined showed significant alterations due 
to myc expression. 
We also analyzed the expression of muscle transcription 
factors belonging to the MyoD family. At the RNA level, 
MyoD seemed somewhat down-regulated by myc in prolifer- 
ating myoblasts, more evidently in C2C12(MMCV).  How- 
ever,  similar MyoD levels were found in all differentiated 
cells, irrespective of their myc expression levels (Fig.  5). 
Myogenin, virtually only expressed in differentiated cells, 
did not show significant variations (Fig. 5). Myf-5 was only 
detected in exceedingly small amounts in our conditions (not 
shown).  MRF4 was undetectable,  in agreement with the 
literature (Rhodes and Konieczny, 1989; Braun et al., 1990; 
Miner and Wold, 1990). Thus, although myc significantly  al- 
tered the phenotype of myocytes, it did not appear to affect 
transcription of the known muscle regulatory genes, at least 
after differentiation. IF staining confirmed the presence of 
MyoD in proliferating cells  and MyoD and myogenin in 
differentiated ones (not shown). Altogether, the data suggest 
that variations of the exogenous myc levels are not required 
for the differentiation of myc-transformed myoblasts. The 
Figure 5. Expression of regulatory factors. Experiments  performed 
as described in the legend to Fig. 4. 
steady-state levels of exogenous myc transcripts were com- 
parable in proliferating and differentiated cells, with the ex- 
ception of C2Cl2(MMCV) (Fig. 5). However, the reduced 
level of v-myc mRNA in differentiated C2Cl2(MMCV)  is 
still  comparable  with that of C2Cl2(c-myc)  and  C2Cl2- 
(v-myc). 
Phenotypic Reversion of C2C12(v-myc) in Mixed 
Culture with Normal Myoblasts or Fibroblasts 
In an attempt to  correct the defective phenotype of myc- 
transformed cells, we cocultivated C2C12(v-myc) along with 
primary quail myoblasts. Cells were seeded together and se- 
rum starved. After differentiation had taken place, the cells 
were fixed and stained to visualize MHC expression and nu- 
clear morphology. As shown in Fig. 6 a,  many myotubes 
contained both quail and mouse nuclei, demonstrating that 
the myc-expressing cells were not impaired in fusing with 
normal  myoblasts.  Hybrid myotubes were  also  observed 
when C2C12(v-myc) were cocultivated with rat L8 myoblasts 
(not shown). Interestingly, we also found that many myo- 
tubes contained only mouse nuclei. These results suggested 
that the presence of normal myoblasts in the culture was also 
able to drive the phenotypic reversion of the transformed 
cells, thus allowing them to fuse with one another. To prove 
this contention, C2C12(v-myc)  were seeded together with 
Rat-2 fibrobasts. As shown in Fig. 6 b, Rat-2 cells induced 
phenotypic reversion of C2C12(v-myc)  that formed large 
multinucleated myotubes. Correction of the fusion-defective 
phenotype could not be achieved by feeding C2C12(v-myc) 
medium conditioned by normal fibroblasts, even when nor- 
mal and transformed cells were in close proximity, but sepa- 
rated by a porous membrane. Thus, it appears that in the 
present system, analogously to previous reports (Bignami et 
al., 1988; La Rocca et al., 1989; Mehta et al.,  1986),  con- 
tact between normal and transformed cells is required to 
override Myc effects. 
Normal Fibroblasts Fail to Promote Fusion of 
Differentiated C2C12(v-myc) Myocytes 
We next asked whether phenotypic correction of C2C12- 
Cresccnzi et al. Reversion of Fusion Defective, myc-transformed  Myoblasts  1141 Figure 6. Cocultivation  of C2C12(v-myc)  and normal cells. Mixed culture of  proliferating C2Cl2(v-myc)  seeded together with quail myoblasts 
(a) or Rat-2 fibmblasts (b), as described in Materials and Methods, and induced to differentiate for three days. (c) Mixed culture of pre- 
differentiated  C2C12(v-myc) myocytes  and quail myoblasts. (d) Mixed culture of pre-differentiated  C2C12(v-myc)  myocytes  and Rat-2 fibro- 
blasts. Ceils were then stained by IF for MHC detection and with Hoechst 33258 to distinguish mouse (speckled) from rat or quail (homoge- 
neous) nuclei. Note the presence of myotubes containing mouse and quail nuclei in a and c, the presence of multinucleated myotubes in b 
but not in d.  Triangles point at mouse nuclei in hybrid myotubes. Bars: (a and c) 25/~m;  (b and d) 50 #m. 
(v-myc) in mixed culture takes place before or after differen- 
tiation.  To distinguish between these two alternatives,  we 
analyzed mixed  cultures  where  the  normal  counterparts, 
quail myoblasts or Rat-2 fibroblasts, were added after C2C12- 
(v-myc) had terminally differentiated. As shown in Fig. 6 c, 
quail  myoblasts were capable of recruiting C2C12(v-myc) 
myocytes, and quail-mouse hybrid myotubes were formed. 
On the contrary, Rat-2 fibroblasts did not induce the fusion 
of  pre-differentiated  C2C12(v-myc) myocytes (Fig. 6 d), thus 
suggesting that myotube formation observed when C2C12(v- 
myc) and Rat-2 cells were coseeded (see Fig. 6 b) represented 
the correction of myc-induced effects and that such correc- 
tion is no longer possible after differentiation has occurred 
in C2C12(v-myc). 
Discussion 
In the present report, we describe the effects of forced ex- 
pression of the myc oncogene in mammalian myoblasts. Sev- 
eral aspects of the resulting phenotype deserve discussion. 
First, despite the cells behaving as fully transformed in vitro, 
they could still differentiate efficiently. Second, although myc 
did  not  significantly  affect biochemical  differentiation or 
commitment, it prevented cell fusion. Third, we found that 
muscle differentiation could prevent myc-induced cell death 
in spite of the continued expression of the oneogene. Finally, 
cocultivation experiments with either fibroblasts or fusion- 
competent myoblasts  showed  that  correction of the  myc- 
induced phenotype in mixed culture can be ascribed to two 
distinguishable mechanisms. 
Several types of myoblasts, transformed by a variety of on- 
cogenes, have been shown to lose their differentiation com- 
petence (reviewed in Alemh and Tatb,  1994). This appears 
to reflect a common finding in in vivo tumors, where malig- 
nancy is usually associated with reduction or loss of differen- 
tiation. C2C12 cells infected with c- or v-myc-transducing 
viruses  showed a  transformed phenotype, as judged from 
faster growth rate, higher saturation density, and anchorage- 
independent proliferation. However, myc-transformed C2C12 
cells retained the ability to differentiate efficiently in  the 
appropriate conditions.  We could show that  14 individual 
MMCV-transformed clones, selected for growth in soft agar, 
all retained the ability to differentiate as efficiently as the 
transformed polyclonal cell population.  We detected con- 
tinued expression of v-Myc protein in differentiated cells. 
Moreover, differentiated ceils maintained  high  expression 
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infected ones.  This strongly  suggests that myc expression 
does not interfere with biochemical differentiation and that 
differentiation does not occur selectively in low myc expres- 
sors. Altogether, these findings demonstrate the coexistence 
of transformation  and  differentiative  potential  within the 
same cell. The fact that, upon serum withdrawal, differentia- 
tion and commitment take place indicates that the differen- 
tiative  mechanism  prevails over the transforming  activity 
of myc. 
Our findings also represent  an instance of uncoupling of 
myotube  formation  from  biochemical  differentiation  by 
means of  an oncogene. A fusion-defective phenotype is phys- 
iologically displayed by early differentiating myoblasts in the 
somites  (VivareUi and Cossu,  1986). Fusion can also be 
prevented in biochemically  differentiated myocytes by ma- 
nipulating environmental conditions, for instance, lowering 
calcium  levels  in  the  medium  (Paterson  and  Strohman, 
1972). These manipulations presumably impair the activity 
of effector molecules necessary for syncitium formation. In 
this case, however, we show that myc specifically interferes 
with that part of  the differentiation programme. Myc proteins 
are currently viewed as trahscriptional regulators that, upon 
heterodimerization  with the appropriate partners  (Amati et 
al., 1993), can either induce (Eilers et al., 1991) or inhibit 
(Yang et al., 1991) the transcription of specific genes. Thus, 
it  is  conceivable  that  the  fusion  defect  of differentiated 
C2C12- (v-myc)  myocytes might depend on the absence of a 
critical gene product specifically required for the fusion pro- 
cess. Alternatively, a functional reduction of  gene product(s) 
required for fusion might prevent homotypic fusion, while 
the residual  function might suffice when fusion into myo- 
tubes is driven by differentiating normal myoblasts. It should 
be stressed that such a phenotype is displayed in the presence 
of presumably functional MyoD and myogenin proteins-as 
inferred from the activation of muscle gene transcription- 
thus suggesting that myc may exert its effects downstream of 
these molecules and/or that fusion is under the direct control 
of different regulators. 
Our results are in agreement with the reported inability of 
deregulated c-myc  to prevent biochemical differentiation in 
BC3H1 cells (Schneider et al., 1987), but appear at variance 
with other reports  in the literature.  In our laboratory, pri- 
mary quail myoblasts infected with myc-transducing viruses 
became transformed but completely lost differentiative po- 
tential  (Falcone  et al.,  1985). MyoD-converted  NIH 3T3 
cells were not transformed by myc but were inhibited from 
differentiating (Miner and Wold, 1991). The phenotype de- 
scribed here is still different, since C2C12 cells were trans- 
formed, but retained the ability to differentiate, though with- 
out fusing into myotubes. It should be noticed that these 
observations have been made in quite different systems, and 
might reflect the phenotypical heterogeneity found in skele- 
tal muscle cells at different developmental stages (Cusella- 
De Angelis et al., 1992). Quail myoblasts, in fact, represent 
fetal myoblasts (Smith et al.,  1993), while the C2C12 cell 
line was derived from adult satellite cells (Yaffe and Saxel, 
1977). We are currently  investigating whether the pheno- 
types of myc-transformed quail myoblasts and C2C12 cells 
are prototypical for myc effects in fetal myoblasts and satel- 
lite cells, respectively, and whether differential modulation 
of the transcription  of myogenic regulatory genes can ac- 
count for the different phenotypes.  In the case of MyoD- 
convened NIH 3T3 (Miner and Wold, 1991), the use of an 
inducible  vector for myc expression  might have allowed 
acute  induction  of high levels of myc that  would prevent 
differentiation but might be incompatible with long term cell 
viability. Our data do not exclude that the same phenomenon 
might also occur in C2C12 cells when using similar induc- 
ible vectors. 
The fact that in C2C12 cells expression of v-myc does not 
inhibit biochemical differentiation allowed us to make an in- 
teresting observation.  In agreement with recent results ob- 
tained using mammalian fibroblasts (Evan et al., 1992), myc 
expression caused extensive cell death after shift to serum- 
free medium, i.e., in conditions not sustaining proliferation. 
However, in the same conditions, differentiated myocytes did 
not die. This finding leads us to conclude that the differentia- 
tion programme  interferes  with  the  mechanism  of myc- 
induced cell death. Mutual exclusion between programmed 
cell death and terminal differentiation was also reported in 
hemopoietic cells (Yonish-Rouach et al., 1991). 
In a series of experiments we explored the possibility of 
correcting  the  fusion  defective  phenotype  of  the  myc- 
expressing cells by cocultivating them with non-transformed 
cells.  We  set  up  mixed  cultures  of  either  replicating 
C2C12(v-myc) or differentiated C2C12(v-myc) myocytes and 
either rat fibroblasts or quail and rat myoblasts. When repli- 
cating C2C12(v-myc) were coseeded with rat fibroblasts, ex- 
tensive fusion was observed after mitogen removal; coculti- 
vation with fusion-competent quail or rat myoblasts gave rise 
to quail/mouse or rat/mouse hybrid myotubes, respectively. 
However when rat fibroblasts were added to differentiated 
C2C12(v-myc) myocytes, myotube formation could not be 
rescued; on the contrary, addition of fusion-competent quail 
myoblasts led to quail/mouse  hybrid myotube formation. 
These findings suggest that correction of the fusion defective 
phenotype can be achieved via two mechanisms: one, involv- 
ing the passive recruitment of C2C12(v-myc) myocytes into 
myotubes formed by differentiating normal myoblasts; the 
other, involving phenotypic reversion of myc-induced trans- 
formed phenotype, actively induced by surrounding normal 
cells, as previously reported for myc-transformed quail myo- 
blasts (La Rocca et al., 1989). In the case of mixed cultures 
of replicating C2C12(v-myc) and normal myoblasts the two 
mechanisms might concur to produce the observed pheno- 
typic correction. 
The data obtained from the analysis of  mixed cultures have 
other interesting implications. The rescue ofmyotube  forma- 
tion  in  mixed  culture  of rat  fibroblasts  and  replicating 
C2C12(v-myc) confirms  and  extends  our previous  results 
with myc-transformed quail myoblasts to a  system that is 
more amenable to further manipulation  and experimenta- 
tion. At the same time, these data strongly argue that myo- 
tube formation in mixed cultures of myc-transformed myo- 
blasts  and normal  fibroblasts cannot be accounted  for by 
mere induction of growth inhibition by surrounding normal 
cells, as C2C12(v-myc) are perfectly competent to withdraw 
from cell cycle by themselves. This conclusion, in turn, rein- 
forces our previous proposal (La Rocca et al., 1989) that fu- 
sion  of myc-transformed myoblasts in mixed culture  with 
normal cells entails the triggering of phenotypic reversion 
from the transformed state. Finally, the inability of normal 
fibroblasts  to  correct  the  fusion  defective  phenotype  of 
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support to the postulated mechanism underlying phenotypic 
reversion  of myc-transformed  cells  in  mixed  culture  with 
normal cells. We had previously suggested that junctional in- 
tercellular  communication  between  myc-transformed  cells 
and surrounding normal cells might play a role in mediat- 
ing the susceptibility  of transformed myoblasts to undergo 
phenotypic reversion.  While  replicating  myoblasts can es- 
tablish  junctional  communication,  differentiated  skeletal 
muscle  cells  display  a  loss  of junctional  competence  (re- 
viewed in Loewenstein,  1979).  Such an important physio- 
logical difference might be responsible for the striking differ- 
ence between  replicating  C2C12(v-myc)  and differentiated 
C2C12(v-myc) myocytes in the ability to fuse in mixed cul- 
ture with normal fihroblasts. 
Further work is still required to clarify the mechanism of 
and the molecules actually involved in this intriguing issue. 
Using the system and the approach here described, it will be 
soon possible to assess whether intercellular communication 
and phenotypic reversion are more generally and mechanis- 
tically involved in the growth inhibition of transformed cells 
in mixed culture with normal cells  (Bignami et al.,  1988; 
Mehta et al.,  1986;  Stoker et al.,  1966). 
We thank the following persons for providing valuable reagents used in this 
study: S. Alenffi, G. Cossu, D. Fischman, C. Goridis, T. Graf, K. Moclling, 
A.  Starzinsld-Powitz,  B.  Vennstr0m, W.  Wright, and D.  Yaffe. We also 
thank A. Calconi and E  Falzini for technical support. 
This work has been supported by grants from Associazione Italiana per 
la Ricerca sul Cancro  (progetto Oncosoppressori);  Consiglio Nazionale 
delle Ricerche (progetto  finalizzato Applicazioni Cliniche della Ricerca 
Oncologica); Fondazione Cenci-Bolognetti. 
Received for publication 19 January 1994. 
References 
Alenfi, S.,  and F. Tat{). 1987.  Interaction  of retroviral oncogenes with the 
differentiation  programme of myogenic cells. Adv.  Cancer Res. 49:1-28. 
Alemh, S., and F. Tatb. 1994. Oncogenes and muscle differentiation:  multiple 
mechanisms of interference. Semin.  Cell Cancer Biol. In press. 
Amati, B., M. W. Brooks, N. Levy, T. D. Litflewood,  G. I. Evan, and H. 
Land. 1993. Oncogerdc activity of the c-Myc protein requires dimerizatiou 
with Max. Cell. 72:233-245. 
Bader, D., T. Masaki, and D. A. Fischman. 1982. Immunochemical analysis 
of myosin heavy chain during avian myogenesis  in rive and in vitro. J. Cell 
Biol.  95:763-770. 
Bengal, E., L. Ransone, R. Scharfmann, V. J. Dwarld, S. J. Tapscott, H. Wein- 
traub, and I.  M. Verma 1992.  Functional antagonism between c-Jun and 
MyoD proteins: a direct physical association. Cell. 68:507-519. 
Bignami, M.,  S.  Rosa, G. Falcone, F. Tat{), F. Katoh, and H.  Yamasaki. 
1988a. Specific viral oncogunes cause differential effects on cell-to-cell com- 
munication, relevant to the suppression  of the transformed phenotype by nor- 
real cells. Molecular Carcinogenesis.  1:67-75. 
Biguami, M.,  S.  Rosa, S.  A. La Rocca, G.  Falcone,  and F.  Tat{). 1988b. 
Differential  influence of adjacent normal cells on the proliferation of mam- 
malian cells transformed by the viral oncogenes  myc, ras and src. Oncogene. 
2:509-514. 
Braun, T., E. Bober, B. Winter, N. Rosenthal, and H. H. Arnold. 1990. Myf-6, 
a new member of  the human gene family of myogenic  determination factors: 
evidence for a gene cluster on chromosome 12. EMBO (Eur. Mol. Biol. Or- 
gan.) J.  9:821-831. 
Clegg, C. H., T. A. Linkhart, B. B. Olwin, and S. D. Hauschka. I'987. Growth 
factor control of skeletal  muscle differentiation:  commitment to terminal 
differentiation occurs in Gt phase and is repressed by fibroblast  growth fac- 
tor. J.  Cell Biol. 105:949-956. 
Crouch, D. H., C. Lang, and D. A. F. Gillespie.  1990. The leucine zipper do- 
main of avian cMyc is required for transformation and autoregulation. On- 
cogene.  5:683-689. 
Cusella-De Angelis,  M.  G.,  G.  Lyons,  C.  Sonnino,  L.  De  Angelis,  E. 
Vivarelli, K. Farmer, W. E. Wright, M. Molinaro, M. Bouche', M. Buck- 
ingham, and {3. Cossu. 1992. MyoD, myogenin independent differentiation 
of primordial myoblasts in mouse somites. J.  Cell Biol. 116:1243-1255. 
Donalies, M., M. Cramer, M. Ringwald, and A. Starzinski-Powitz.  1991. Ex- 
pression of M-cadherin, a member of the cadherin multigene family, corre- 
lates with differentiation  of skeletal  muscle cells. Proc.  Natl. Acad. Sci. 
USA. 88:8024-8028. 
Edelman, G. E., and K. L. Crossin. 1991. Cell adhesion molecules: implica- 
tions for a molecular histology. Annu. Rev.  Biochem. 60:155-190. 
Eilers, M., S. Schirm, and J. M. Bishop. I991. The Myc protein activates tran- 
scription of the a-prothymosin gene. EMBO  (Eur. Mol. Biol. Organ.) J. 
10:133-141. 
Evan, G. I.,  A. H. Wyllie, C. S. Gilbert,  T.  D. Littlewood,  H. Land, M. 
Brooks, C. M. Waters, L. Z. Penn, and D. C. Hancock.  1992. Induction 
of apoptosis  in fibroblasts  by c-myc protein.  Cell. 69:119-128. 
Falcone,  G., F. Tatb,  and S. Alemtt.  1985.  Distinctive  effects  of  the  viral  on- 
cogenes myc, erb,  fps,  and  src  on  the  differentiation  program of  quail  myo- 
gunic cells.  Prec. Natl. Acad. Sci. USA. 82:426-430. 
Falcone,  O., S. Alenfi,  and F. Tatb. 1991.  Transcription  of muscle-specific 
genes is repressed  by reactivation  of pptO  ~  in postmitotic  quail  myo- 
tubes. Mol. Cell. Biol. 11:3331-3338. 
Grossi, M., A. Calconi, and F. Tat{). 1991. v-jan oncogene prevents terminal 
differentiation  and suppresses muscle-specific gene expression in ASV-17- 
infected muscle cells. Oncogene. 6:1767-1773. 
Konieczny, S. F., B. L. Drobes, S. L. Menke, and E. J. Taparowsky. 1989. 
Inhibition of myogenic differentiation  by the H-ras oncogene is associated 
with the down regulation of the MyoDI gane. Oncogene. 4:473-481. 
La Rocca, S. A., M. Grossi, O. Falcone, S. Alem~t, and F. Tat{). 1989. Interac- 
tion with normal cells suppresses the transformed phenotype of v-myc- 
transformed quail muscle cells. Cell. 58:123-131. 
Land, H., L. F. Parada, and R. A. Weinberg. 1983. Tumorigenic conversion 
of primary embryo fibroblasts requires at least two cooperating oncogenes. 
Nature (Lend.).  304:596-602. 
Lassar, A. B., M. J. Thayer, R. W. Overell, and H. Weintraub. 1989. Trans- 
formation by activated ras orfos prevents myogenesis  by inhibiting expres- 
sion of MyoDl.  Cell. 58:659-667. 
Lathrop, B. K., B. N. Olson, and L. Glaser. 1985. Control by fibroblast growth 
factor  of differentiation  in  the  BC3H1 muscle cell  line.  J.  Cell Biol. 
100:1540-1547. 
Locwanstein, W. R. 1979. Junctional intercellular communication and the con- 
trol of growth. Biochim. Biophys. Acta. 560:1-65. 
Liischer, B., and R. N. Eisnnman. 1990. New light on Myc and Myb. Part I. 
Myc. Genes Dev. 4:2025-2035. 
Malone, R., G. M. Fimia, and P. Amati. 1992. Inhibition of in vitro myogenic 
differentiation  by a polyomavirus early function. Oncogene. 7:85-93. 
Mann, R.,  R.  C.  Mulligan, and D. B. Baltimore.  1983.  Construction of a 
retrovirus packaging mutant and its use to produce helper-free defective 
retrovirus. Cell. 33:153-159. 
Mehta, P. P., J. S. Bertram, and W. R. Loewenstcin. 1986. Growth inhibition 
of transformed cells correlates with their junctional communication  with nor- 
mal cells. Cell. 44:187-196. 
Miner, J. H., and B. Wold.  1990.  Herculin, a fourth member of the MyoD 
family of myogenic regulatory genes. Prec.  Natl. Acad. Sci. USA. 87: 
1089-1093. 
Miner, J. H., and B. J. Wold. 1991. c-myc inhibition of MyoD and myogenin- 
initiated  myogenic differentiation.  Mol. Cell. Biol. 11:2842-2851. 
Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: 
high titre retroviral vectors with multiple drug selection markers and a com- 
plementary helper-free packaging cell  line. Nucleic Acids  Res. 18:3587- 
3596. 
Olson, E. N.  1990.  MyoD family: a paradigm for development? Genes Dev. 
4:1454-1461. 
Paterson, B., and R. Strohman. 1972. Myosin synthesis  in cultures of differcn- 
flaring chicken embryo skeletal  muscle. Dev.  Biol. 29:113-138. 
Pearson, M. L., and H. F. Epstein. 1982. Muscle development: molecular and 
cellular control. Cold Spring Harbor Laboratory, Cold Spring Harbor, N-Y. 
581 pp. 
Rhodes, S. J., and S. F. Konieczny. 1989. Identification of MRF4: a new mem- 
ber of the muscle regulatory factor gene family. Genes Dev. 3:2050-2061. 
Schneider, M. D., and E. N. Olson. 1988. Control of myogenic differentiaflo~ 
by cellular oncogenes. Mol. Neurobiol.  2:1-39. 
Schneider, M. D., M. B. Perryman, P. A. Payne, G. Spizz,  R. Roberts, and 
E. N. Olson. 1987.  Autonomous expression of c-myc in BC3H1 cells par- 
tially inhibits but does not prevent myogenic  differentiation.  Mol. Cell. Biol. 
7:1973-1977. 
Schubert, D., J. Harris, C. E. Devine, and S. Heineman. 1974. Characteriza- 
tion of a unique muscle cell line. J.  Cell Biol. 61:398-413. 
Smith, T. H., N. E. Block,  S. J. Rhodes, S. F. Konieczny, and J. B. Miller. 
1993.  A unique pattern of expression of the four muscle regulatory factol 
proteins distinguishes semitic from embryonic, fetal and newborn mouse 
myogenic cells. Development.  117:1125-1133. 
Stoker, M.  G. P., M.  Shearer, and C. O'Neill.  1966.  Growth inhibition el 
polyoma-transformcd  cells by contact with static normal fibroblasts.  J.  Cel, 
Sci.  1:297-310. 
Vennstrtm, B., P. Kahn, B. Adkins, P. Enrietto, M. J. Hayman, T. Graf, an¢ 
P. Luciw. 1984. Transformation  of mammalian  fibroblasts and macrophage~ 
The Journal of Cell Biology, Volume 125,  1994  1144 in vitro by a murine retrovirus encoding an avian v-myc oncogene. EMBO 
(Eur. Mol.  Biol.  Organ.)J.  3:3223-3229. 
VivareUi, E., and G. Cossu. 1986. Neural control of  early myogenic  differentia- 
tion in cultures  of mouse somites. Dev.  Biol.  107:2191-2198. 
Walter, N., C. Jansen, C. Trachmann, and K. Bister.  1986. Nucleotide  se- 
quence of the CMII v-myc allele.  Virology.  154:219-223. 
Weinberg, R. A. 1989. Oncogenes and the molecular origins of cancer. Cold 
Spring Harbor Laboratory  Press, Cold Spring Harbor. 307-326. 
Weintraub,  H., R. Davis,  S. Tapscott,  M. Thayer, M. Krause,  R. Benezra, 
K.  T. Black-well, D. Turner, R. Rupp, S. HoUenberg, Y. Zhttang,  and A. 
Lassar.  1991. The myoD gene family: nodal point during specification of the 
muscle cell lineage.  Science  (Wash. DC).  251:761-766. 
Wright, W. E., M. Binder, and W. Funk. 1991. Cyclic amplification and target 
selection  (casting)  for the myogenin binding site.  Mol.  Cell.  BioL  11: 
4104-4111. 
Yaffe, D., and O. Saxel. 1977. Serial passaging and differentiation of  myogenic 
cells isolated from dystrophic mouse muscle. Nature (Lond.). 270:725-727. 
Yang, B.-S., T. ]. Gcddes, R. I. Pogulis, B. de Crombmgghe, and S. O. Frey- 
tag. 1991. Transcriptional suppression  of  cellular gene expression  by c-Myc. 
Mol.  Cell. Biol.  11:2291-2295. 
Yonish-Roanch, E., D. Resnitzky,  J. Lotem, L. Sachs,  A. Kimchi, and M. 
Oren. 1991. Wild-type  p53 induces apoptosis of  mycloid leukaemic cells that 
is inhibited by interleukin-6.  Nature  (Lond.).  352:345-347. 
Crescenzi et al. Reversion  of Fusion Defective,  myc-transformed  Myoblasts  1145 